News Results
There are 797,783 News Results
Feb 24, 2022
Western Midstream Partners, LP (NYSE: WES): Reported fourth-quarter 2021 Net income attributable to limited partners of $238.2 million, generating fourth-quarter Adjusted EBITDA(1) of $480.9 million, which included $26.2 million of...
Apr 27, 2022
Hess Corporation (NYSE: HES) today reported net income of $417 million, or $1.34 per share, in the first quarter of 2022, compared with net income of $252 million, or $0.82...
Jun 7, 2022
NGL Energy Partners LP (NYSE:NGL) (“NGL,” “our,” “we,” or the “Partnership”) today reported its fourth quarter and full year fiscal 2022 results. The Partnership reported a loss from continuing operations...
Oct 26, 2022
Hess Corporation (NYSE: HES) today reported net income of $515 million, or $1.67 per common share, in the third quarter of 2022, compared with net income of $115 million, or...
Jun 1, 2023
NGL Energy Partners LP (NYSE:NGL) (“NGL,” “our,” “we,” or the “Partnership”) today reported its fourth quarter and full year fiscal 2023 results. Highlights for the fiscal year and quarter ended...
Jul 26, 2023
Hess Corporation (NYSE: HES) today reported net income of $119 million, or $0.39 per share, in the second quarter of 2023, compared with net income of $667 million, or $2.15...
Jan 31, 2024
Hess Corporation (NYSE: HES) today reported net income of $413 million, or $1.34 per share, in the fourth quarter of 2023, compared with net income of $497 million, or $1.61...
Feb 9, 2024
NGL Energy Partners LP (NYSE:NGL) (“NGL,” “we,” “us,” “our,” or the “Partnership”) today reported its third quarter Fiscal 2024 financial results. Highlights include: Net income for the third quarter of...
May 16, 2024
Chemtrade Logistics Income Fund (TSX: CHE.UN) (“Chemtrade” or the “Fund”) today announced results for the three months ended March 31, 2024. The financial statements and MD&A will be available on...
May 23, 2024
Biomarker Analyses from Pivotal Phase 3 CLEAR Trial in Patients with Advanced Renal Cell Carcinoma Will Be Featured in an Oral Presentation
